SCHEMBL5502576

SCHEMBL5502576

CCCCCC(O)(O)C(=O)O.[NaH]

nearest known ligand 0.52

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
FDPS P14324 9/20 0.45
GGPS1 O95749 6/20 0.45
AKR1B1 P15121 1/20 0.42
CES2 O00748 1/20 0.42
GPR84 Q9NQS5 2/20 0.41
PPARG P37231 2/20 0.41
PPARD Q03181 2/20 0.41
PPARA Q07869 2/20 0.41
ALDH1A1 P00352 1/20 0.41
TSHR P16473 1/20 0.41
SLC22A6 Q4U2R8 1/20 0.41
SLC22A8 Q8TCC7 1/20 0.41
TLR2 O60603 1/20 0.41
HDAC11 Q96DB2 1/20 0.41
TDP1 Q9NUW8 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL945896 0.98 FDPS (0.46) FDPSGGPS1AKR1B1CES2GPR84
SCHEMBL6230681 0.95 FDPS (0.45) FDPSGGPS1AKR1B1CES2GPR84
SCHEMBL6056814 0.95 FDPS (0.48) FDPSGGPS1CES2GPR84PPARG
SCHEMBL6056806 0.95 FDPS (0.48) FDPSGGPS1CES2GPR84PPARG
SCHEMBL1990820 0.95 FDPS (0.48) FDPSGGPS1CES2GPR84PPARG
SCHEMBL1916481 0.95 FDPS (0.48) FDPSGGPS1CES2GPR84PPARG
SCHEMBL7172854 0.95 FDPS (0.48) FDPSGGPS1CES2GPR84PPARG
SCHEMBL6056892 0.95 FDPS (0.48) FDPSGGPS1CES2GPR84PPARG
SCHEMBL6056832 0.95 FDPS (0.48) FDPSGGPS1CES2GPR84PPARG
SCHEMBL6056853 0.95 FDPS (0.48) FDPSGGPS1CES2GPR84PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1819681-A1 7-(2H-PYRAZOL-3-YL)-3,5-DIHYDROXY-HEPTANOIC ACID DERIVATIVES AS HMG CO-A REDUCTASE INHIBITORS FOR THE TREATMENT OF LIPIDEMIA Warner-Lambert Company LLC (US) 2007-08-22 EP disclosed
WO-2006056845-A1 7-(2H-PYRAZOL-3-YL)-3, 5-DIHYROXY-HEPTANOIC ACID DERIVATIVES AS HMG CO-A REDUCTASE INHIBITORS FOR THE TREATMENT OF LIPIDEMIA WARNER-LAMBERT COMPANY LLC (US) 2006-06-01 WO disclosed
EP-1521743-A1 HMG-COA REDUCTASE INHIBITORS Ranbaxy Laboratories Limited (IN) 2005-04-13 EP disclosed
WO-2004005250-A1 HMG-COA REDUCTASE INHIBITORS RANBAXY LABORATORIES LIMITED (IN) 2004-01-15 WO disclosed